In line with this evidence, piceatannol, but not CE, inhibited the infection of pseudotype particles of vesicular stomatitis virus (VSV) G proteins (IC50 = 79.23 ± 17.20 μM, Table 1), indicating that piceatannol inhibits HIV-1 entry independently of any receptors. This evidence concerns the gene PROS1 and infection.